Abstract
Objective
To determine the incidence and survival time of acquired immunodeficiency syndrome-related malignancies among HIV-infected population.
Methods
A clinical database search, chart review and verification with health records were undertaken for all AIDS-defining cancers diagnosed in Zhongnan Hospital Wuhan University, Hubei Province, China. Kaplan–Meier method was used to evaluate survival time in HIV-infected patients with cancer.
Results
A total of 3,554 patients with 11,072 person-years of HIV follow-up care were reviewed from January 2004 to December 2008. Sixty-three cancer cases were identified. The median ages of HIV-positive cancer cases were 42.4 ± 8.8 years, CD4 count were 220.9 ± 142.3/µl. The common cancers were non-Hodgkin’s lymphoma (NHL, 28.6%), cervical cancer (22.2%), liver cancer (17.5%). Statistically significantly elevated SIRs were observed in NHL (SIR in all = 34.5, 95% CI 11.7–89.9, SIR in males = 45.3, 95% CI 24.7–138.9, females = 12.2, 95% CI 3.9–38.2), invasive cervical cancer (SIR = 68.1, 95% CI 19.2–84.5), liver cancer (SIR = 6.0, 95% CI 2.6–12.2), nasopharyngeal cancer (SIR = 6.2, 95% CI 1.5–44.9), bladder cancer (SIR = 4.9, 95% CI 0.9–22.9), esophageal cancer (SIR = 3.1, 95% CI 0.7–14.3), and stomach cancer (SIR = 2.6, 95% CI 0.6–11.6). All cancers combined showed a statistically significantly elevated SIR of 4.1 (95% CI 2.5–4.6), SIR for all cancers was much higher in female (SIR = 4.8, 95% CI 3.2–7.3) than in male (SIR = 3.1, 95% CI 2.1–4.3). Among HIV-positive patients with cancer, the median survival time was 14.5 ± 3.8 months in NHL group, 28.9 ± 3.6 months in cervix group, 5.1 ± 1.1 months in liver group, and 26.7 ± 6.7 months in other groups. The median survival time in HIV-infected group (23.1 ± 3.5 months) was shorter than that in non-HIV-infected group (43.0 ± 5.1 months), (P < 0.05).
Conclusions
NHL, cervical cancers and liver cancer are common cancers among HIV-infected individuals in Hubei, China. Most malignant diseases that arise in the setting of HIV infection tend to occur at a more advanced stage with shorter survival time.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barbaro G, Barbarini G (2007) HIV infection and cancer in the era of highly active antiretroviral therapy (review). Oncol Rep 17(5):1121–1126
Boue F, Gabarre J, Gisselbrecht C, Reynes J, Cheret A, Bonnet F et al (2006) Phase II trial of CHOP pius rituximab in patients with HIV-associated non-Hodgkin’s lymphoma. J Clin Oncol 24:4123–4128
China CDC (2008) HIV/AIDS prevalence and challenge in China. China CDC, 12.2
Clifford GM, Polesel PS, Rickenbach M, Dal Maso L, Keiser O, Kofler A et al (2005) Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97:425–432
Dal Maso L, Serraino D, Franceschi S (2001) Epidemiology of AIDS-related tumors in developed and developing countries. Eur Cancer 37:1188–1201
Dal Maso L, Franceschi S, Polesel J, Braga C, Piselli P, Crocetti E et al (2003) Risk of cancer in person with AIDS in Italy, 1985–1998. Br J Cancer 89:94–100
Dhir AA, Sawant S, Dikshit RP, Parikh P, Srivastava S, Badwe R et al (2008) Spectrum of HIV/AIDS related cancers in India. Cancer Cause Control 19:147–153
Frisch M, Biggar RJ, Engels EA, Goedert JJ (2001) Association of cancer with AIDS-related immunosuppression in adults AIDS-Cancer Match Registry Study Group. JAMA 285(13):1736–1745
Goedert JJ, Cote TR, Virgo P, Scoppa SM, Kingma DW, Gail MH et al (1998) Spectrum of AIDS-associated malignant disorders. Lancet 351:1833–1839
Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C et al (2003) Increase of non-AIDS defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus infected patients. J Clin Oncol 21:3447–3453
Jermal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249
Maiman M, Fructer R, Serur E, Arrastia CD, Matthews R, Gates EJ et al (1997) Cervical cancer as an AIDS-defining illness. Obstet Gynecol 89:76–80
MMWR (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41:961–962
Newcomb-fernandez J (2003) Cancer in the HIV-infected population. Res Initial Treat Action 9:5–13
Parkin DM, Whelan SL, Ferlay J, Thomas DB, Teppo L (eds) (2002) Cancer incidence in five continents, Vol VIII. IARC Scientific Publications No. 155. International Agency for Research on Cancer, Lyon (France)
Portsmouth S, Stebbing J, Gill J, Mandalia S, Bower M, Nelson M et al (2003) A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi’s sarcoma. AIDS 17:F17–F22
Ratner L, Jeannette L, Tang SH, Redden D, Hamzeh F, Hernadier B et al (2001) Chemotherapy for human immunodeficiency virus-associated non-Hodgkin’s lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol 19(8):2171–2178
Rong-Rong Y, Gui Xi-En, Shi-Cheng G, Yong-Xi Z (2008) Interaction of hepatitis B and C Viruses in patients infected with HIV. J Acquir Immune Defic Syndr 48:491–492
Sherer R, Gui X, Zhan F, Teter C, Ping DL, Wykoff RF et al (2008) Rapid antiretroviral therapy scale-up in Hubei province, China. Health Aff (Millwood) 27:1140–1147
Siwei Z, Wanqing C, Lingzhi G, Guanglin L, Ping L (2007) An annual report: cancer incidence in 35 cancer registries in China, 2003. J Chin Cancer 16:494–507
Sriplung H, Parkin MD (2004) Trends in the incidence of acquired immunodeficiency syndrome-related malignancies in Thailand. Cancer 101:2660–2665
Thio CL, Seaberg EC, Skolasky R, Phair J, Visscher B, Munoz A et al (2002) HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohor Study (MACS). Lancet 360:1921–1927
Wabinga HR, Parkin DM, Warbwire-Mangen F, Nambooze S (2000) Trends in cancer incidence in Kyadondo Country, Uganda, 1960–1997. Br J Cancer 82:1585–1592
Xiong-ming P, Wei-dong W, Xiao-jing K (2003) Clinical and experimental study on thirty-eight patients with classic Kaposi’s sarcoma in the XingJiang Uighur autonomous region. J Clin Dermatol 32(Suppl):S25–S31
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, Yx., Gui, Xe., Zhong, Yh. et al. Cancer in cohort of HIV-infected population: prevalence and clinical characteristics. J Cancer Res Clin Oncol 137, 609–614 (2011). https://doi.org/10.1007/s00432-010-0911-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-010-0911-y